论文部分内容阅读
1基本情况患儿,男,汉族,2016年1月9日出生,散居儿童;无食物、药物过敏史,无家族性传染及遗传病史;在本次口服脊髓灰质炎(脊灰)减毒活疫苗(OPV)前,精神尚可,发育正常,营养中等,大小便正常,已按免疫程序完成了卡介苗和第1、2 剂乙型肝炎疫苗的接种,未出现疑似预防接种异常反应(AEFI)。2 发病和临床经过2016年3月28日10时左右,患儿在某村卫生所口服一粒OPV,约半小时后离开卫生所回家;4月16日,患儿母亲
1 Basic information Children, male, Han nationality, was born on January 9, 2016, scattered children; no food, drug allergy history, no family history of infection and genetic history; oral live in this polio (polio) attenuated live vaccine (OPV), the spirit is acceptable, normal development, moderate nutrition, normal urine, has completed the immunization program BCG and the first and second dose of hepatitis B vaccine inoculation, no suspected antivirus vaccination response (AEFI). 2 incidence and clinical After about 10 o’clock on March 28, 2016, children with oral OPV in a village clinics, about half an hour after leaving the clinic to go home; April 16, children and mothers